Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of axillary block onset, duration, and quality with ropivacaine 0.5% plus dexmedetomidine, fentanyl, or verapamil in forearm surgeries
IRCT20141209020258N111Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Jan 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial comparing Ropivacaine + dexmedetomidine, Ropivacaine + fentanyl and Ropivacaine + verapamil (3 arms). Primary endpoints: Onset time of axillary block, Duration of axillary block and 1 more. Started Jan 2019; status: completed.
02
Drugs
ropivacainedexmedetomidinefentanylverapamil
Beyond the preview
Go deeper on IRCT20141209020258N111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141209020258N111.